Heron Therapeuti Stock Number Of Shares Shorted

HRTX Stock

USD 1.22 0.03 2.52%

Heron Therapeuti fundamentals help investors to digest information that contributes to Heron Therapeuti's financial success or failures. It also enables traders to predict the movement of Heron Stock. The fundamental analysis module provides a way to measure Heron Therapeuti's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Heron Therapeuti stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Heron Therapeuti Company Number Of Shares Shorted Analysis

Heron Therapeuti's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

Shares Shorted

Shorted by Public

+

by Institutions

More About Number Of Shares Shorted | All Equity Analysis

Current Heron Therapeuti Number Of Shares Shorted

27.91 M

Most of Heron Therapeuti's fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Heron Therapeuti is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Heron Number Of Shares Shorted Driver Correlations

Understanding the fundamental principles of building solid financial models for Heron Therapeuti is extremely important. It helps to project a fair market value of Heron Stock properly, considering its historical fundamentals such as Number Of Shares Shorted. Since Heron Therapeuti's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Heron Therapeuti's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Heron Therapeuti's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Common Stock	Short Term Investments	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Capital Surpluse	Short Long Term Debt	Long Term Debt Total	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.78	0.07	-0.65	0.78	0.5	1.0	0.41	0.35	-0.06	0.88	0.6	0.7	0.82	0.76	0.31	0.83	0.85	0.85	0.27
Total Stockholder Equity	0.78		-0.51	-0.04	0.29	-0.15	0.83	0.28	0.34	-0.19	0.87	-0.01	0.22	0.99	0.2	0.09	0.4	0.9	0.9	-0.31
Net Debt	0.07	-0.51		-0.7	0.51	0.81	0.0	-0.26	-0.2	0.27	-0.05	0.75	0.49	-0.44	0.61	-0.07	0.34	-0.16	-0.16	0.83
Retained Earnings	-0.65	-0.04	-0.7		-0.88	-0.97	-0.58	-0.29	-0.06	-0.15	-0.34	-0.98	-0.83	-0.12	-0.98	-0.34	-0.85	-0.24	-0.24	-0.84
Net Receivables	0.78	0.29	0.51	-0.88		0.83	0.75	0.44	0.39	0.13	0.55	0.83	0.89	0.38	0.92	0.49	0.91	0.45	0.46	0.66
Total Liab	0.5	-0.15	0.81	-0.97	0.83		0.43	0.25	0.08	0.17	0.2	0.96	0.8	-0.07	0.93	0.37	0.76	0.1	0.1	0.86
Total Current Assets	1.0	0.83	0.0	-0.58	0.75	0.43		0.42	0.4	-0.08	0.91	0.53	0.66	0.87	0.7	0.32	0.8	0.88	0.88	0.2
Short Term Debt	0.41	0.28	-0.26	-0.29	0.44	0.25	0.42		0.62	-0.14	0.13	0.15	0.48	0.29	0.32	0.95	0.58	0.1	0.1	0.04
Accounts Payable	0.35	0.34	-0.2	-0.06	0.39	0.08	0.4	0.62		-0.2	0.33	-0.08	0.3	0.34	0.1	0.66	0.36	0.26	0.27	-0.2
Common Stock	-0.06	-0.19	0.27	-0.15	0.13	0.17	-0.08	-0.14	-0.2		-0.11	0.19	0.22	-0.16	0.12	-0.06	0.07	-0.08	-0.07	0.27
Short Term Investments	0.88	0.87	-0.05	-0.34	0.55	0.2	0.91	0.13	0.33	-0.11		0.3	0.46	0.9	0.48	0.02	0.56	0.96	0.97	0.03
Property Plant Equipment	0.6	-0.01	0.75	-0.98	0.83	0.96	0.53	0.15	-0.08	0.19	0.3		0.79	0.07	0.96	0.22	0.78	0.24	0.24	0.85
Current Deferred Revenue	0.7	0.22	0.49	-0.83	0.89	0.8	0.66	0.48	0.3	0.22	0.46	0.79		0.29	0.86	0.52	0.87	0.41	0.41	0.61
Net Tangible Assets	0.82	0.99	-0.44	-0.12	0.38	-0.07	0.87	0.29	0.34	-0.16	0.9	0.07	0.29		0.28	0.11	0.46	0.92	0.92	-0.22
Capital Surpluse	0.76	0.2	0.61	-0.98	0.92	0.93	0.7	0.32	0.1	0.12	0.48	0.96	0.86	0.28		0.35	0.88	0.4	0.4	0.77
Short Long Term Debt	0.31	0.09	-0.07	-0.34	0.49	0.37	0.32	0.95	0.66	-0.06	0.02	0.22	0.52	0.11	0.35		0.57	-0.02	-0.02	0.16
Long Term Debt Total	0.83	0.4	0.34	-0.85	0.91	0.76	0.8	0.58	0.36	0.07	0.56	0.78	0.87	0.46	0.88	0.57		0.47	0.47	0.62
Net Invested Capital	0.85	0.9	-0.16	-0.24	0.45	0.1	0.88	0.1	0.26	-0.08	0.96	0.24	0.41	0.92	0.4	-0.02	0.47		1.0	-0.11
Net Working Capital	0.85	0.9	-0.16	-0.24	0.46	0.1	0.88	0.1	0.27	-0.07	0.97	0.24	0.41	0.92	0.4	-0.02	0.47	1.0		-0.1
Capital Stock	0.27	-0.31	0.83	-0.84	0.66	0.86	0.2	0.04	-0.2	0.27	0.03	0.85	0.61	-0.22	0.77	0.16	0.62	-0.11	-0.1

Click cells to compare fundamentals

If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.

Competition

Predict Heron Therapeuti

Based on the recorded statements, Heron Therapeuti has 27.91 M of outstending shares currently sold short by investors. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The number of shares shorted for all United States stocks is significantly lower than that of the firm.

Heron Number Of Shares Shorted Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heron Therapeuti's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heron Therapeuti could also be used in its relative valuation, which is a method of valuing Heron Therapeuti by comparing valuation metrics of similar companies.

Heron Therapeuti is currently under evaluation in number of shares shorted category among its peers.

Heron Fundamentals

	Return On Equity	-24.09
	Return On Asset	-0.0231
	Profit Margin	(0.20) %
	Operating Margin	(0.14) %
	Current Valuation	292.91 M
	Shares Outstanding	152.1 M
	Shares Owned By Insiders	0.71 %
	Shares Owned By Institutions	81.56 %
	Number Of Shares Shorted	27.91 M
	Price To Earning	(5.15) X
	Price To Book	12.60 X
	Price To Sales	1.35 X
	Revenue	127.04 M
	Gross Profit	(50.51 M)
	EBITDA	(103.79 M)
	Net Income	(110.56 M)
	Cash And Equivalents	83.54 M
	Cash Per Share	0.81 X
	Total Debt	179.63 M
	Debt To Equity	6.64 %
	Current Ratio	1.77 X
	Book Value Per Share	(0.26) X
	Cash Flow From Operations	(58.79 M)
	Short Ratio	14.98 X
	Earnings Per Share	(0.16) X
	Price To Earnings To Growth	(0.18) X
	Target Price	6.0
	Number Of Employees	126
	Beta	1.81
	Market Capitalization	185.56 M
	Total Asset	222.51 M
	Retained Earnings	(1.91 B)
	Working Capital	109.09 M
	Current Asset	134.75 M
	Current Liabilities	19.73 M
	Net Asset	222.51 M

About Heron Therapeuti Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Heron Therapeuti's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heron Therapeuti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heron Therapeuti based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Additional Tools for Heron Stock Analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC